Updated Jul 16, 2026
Azelby Robert has filed 4 SEC Form 4 filings across 4 companies in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | TNGX | Tango Therapeutics, Inc. | A — Grant or award | 5.7K | $0.00 | |
| 2026-06-03 | ADCT | ADC Therapeutics SA | F — Tax withholding / forfeiture | 12.6K | $3.08 | $39K |
| 2026-06-03 | ADCT | ADC Therapeutics SA | A — Grant or award | 45.0K | $0.00 | |
| 2024-11-07 | CAH | CARDINAL HEALTH INC | A — Grant or award | 1.7K | $0.00 |
Azelby Robert is a corporate insider — currently tracked as Director of Autolus Therapeutics plc (AUTL). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 4 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Azelby Robert profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.